Glenn M. Chertow
Publication Details
-
Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial.
J Nephrol. 2012 May-Jun; (3): 302-9
The US National Institutes of Health (NIH) and Centers for Medicare and Medicaid Services (CMS) sponsored a randomized clinical trial comparing six versus three times per week in-center hemodialysis (the Frequent Hemodialysis Network [FHN] Daily Trial), to test the effects of frequent hemodialysis on an array of intermediate outcomes. Herein we report challenges to enrollment and randomization into the trial.
Help